Congo Initiates First Mpox Vaccination Campaign to Combat Outbreak
Congo has launched its first mpox vaccination campaign in Goma to tackle the outbreak spreading across African nations, addressing previous vaccine access inequities.
PublicHealth
Read More
WHO’s First Emergency Mpox Test Approved, Boosting Global Health Response
WHO has approved the first emergency mpox diagnostic test, enhancing global efforts to detect and manage outbreaks.
FDA Approves Self-Administered Nasal Flu Vaccine for U.S. Consumers
The FDA has approved the first nasal spray flu vaccine for self-administration, offering a needle-free, convenient option as the U.S. prepares for the upcoming flu season.
Africa CDC and WHO Unveil $600M Plan to Combat Rising Mpox Cases
Africa CDC and WHO launch a $600 million response plan to address the rising mpox cases across the continent, focusing on the DRC epicenter.
China’s State Council Information Office Engages Health Experts in Press Meeting
China’s State Council Information Office invites leading health professionals to a press meeting, fostering open dialogue and enhancing public trust through transparent communication.
WHO Confirms Mpox Is Not a New COVID-19 Threat
WHO assures mpox is not the new COVID-19, emphasizing that existing control measures are effective in managing its spread globally.
Record Heatwave in Japan: Heatstroke Cases Surge by 20% in July
Japan’s heatwave in July 2024 led to a 20% increase in heatstroke cases, marking the second-highest number since 2008, with sweltering temperatures claiming 62 lives.
African Scientists Alert: Mosquito-Borne Diseases on the Rise
African scientists warn of a troubling increase in mosquito-borne diseases like malaria and dengue fever, exacerbated by climate change and impacting public health and economic growth.
Norway and Netherlands Gear Up for New Mpox Variant Amid European Alert
Norway and the Netherlands heighten alert for a new mpox variant after Sweden’s first Clade I case, ensuring robust health preparedness and vaccine availability.
WHO Declares Mpox a Global Health Emergency Amid Rising Cases
WHO declares mpox a public health emergency, highlighting rising cases and the risk of further spread. The EU and biotech firms are responding with vaccine donations.